$STE is heading into Q1 earnings with steady expectations, as investors look for consistent demand in medical devices and sterilization services. The company has benefited from stable healthcare spending and recurring service revenue, which has helped support long-term growth even in a slower macro environment. The main focus this quarter is whether $STE can keep margins stable while continuing to grow revenue at a moderate but reliable pace.